[CME: Heart Failure- Overview, Clinical Manifestation, Diagnosis and Management].

CME: Heart Failure- Overview, Clinical Manifestation, Diagnosis and Management Heart failure is one of the most common diseases in internal medicine with estimated more than 10 million patients in Europe. Another 10 million people suffer from myocardial insufficiency without symptoms. Along with injuries and pathologies of the musculoskeletal system, heart failure is one of the most common causes for hospitalization also in Switzerland.

High Incidence of Inappropriate Alarms in Patients with Wearable Cardioverter-Defibrillators: Findings from the Swiss WCD Registry.

Background: The wearable cardioverter defibrillator (WCD) uses surface electrodes to detect arrhythmia before initiating a treatment sequence. However, it is also prone to inappropriate detection due to artefacts.

Objective: The aim of this study is to assess the alarm burden in patients and its impact on clinical outcomes.

Use of the wearable cardioverter-defibrillator - the Swiss experience.

Introduction: Sudden cardiac death caused by malignant arrhythmia can be prevented by the use of defibrillators. Although the wearable cardioverter defibrillator (WCD) can prevent such an event, its role in clinical practice is ill defined. We investigated the use of the WCD in Switzerland with emphasis on prescription rate, therapy adherence and treatment rate.

Marfan syndrome and related connective tissue disorders in the current era in Switzerland in 103 patients: medical and surgical management and impact of genetic testing.

Introduction: Marfan syndrome (MFS) and related connective tissue disorders (CTDs) are increasingly recognised. Genetic testing has greatly improved the diagnostic outcome/power over the last two decades. In this study we describe a multicentre cohort of adults with MFS and related CTDs, with a particular focus on results from genetic testing.